Geode Capital Management
PBLA

Geode Capital Management’s Panbela Therapeutics, Inc. Common Stock PBLA Stock Holding History

Geode Capital Management’s Portfolio PBLA Stock Details PBLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-794
Closed -$14.5K – 4733
2023
Q4 		$14.5K Hold
794
– – ﹤0.01% 4558
2023
Q3 		$19.9K Buy
+794
New +$26.6K ﹤0.01% 4629
2023
Q1 		– Sell
-1
Closed -$1K – 4957
2022
Q4 		$1K Hold
1
– – ﹤0.01% 4897
2022
Q3 		$3K Hold
1
– – ﹤0.01% 5021
2022
Q2 		$9K Hold
1
– – ﹤0.01% 4990
2022
Q1 		$29K Buy
+1
New +$46.1K ﹤0.01% 4905

Geode Capital Management's PBLA Position: Q1 2024 in Review

Geode Capital Management sold out of Panbela Therapeutics, Inc. Common Stock (PBLA) in Q1 2024, closing a stake of 794 shares — an estimated $14.5K sold.

Geode Capital Management first reported a position in PBLA in Q1 2022 and held it in 6 quarters. The position peaked at $29K in Q1 2022. 0 funds tracked by Wall St. Rank hold PBLA as of Q1 2024.

  • Geode Capital Management reported no remaining Panbela Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Geode Capital Management sold 794 Panbela Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $14.5K.
  • Geode Capital Management first reported a position in Panbela Therapeutics, Inc. Common Stock in Q1 2022 and held it in 6 quarters.
  • Geode Capital Management's Panbela Therapeutics, Inc. Common Stock position peaked at $29K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Panbela Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.